PC01.03 PRO IO in Mesothelioma Should Only Be Given on Clinical Trials
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.093
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV
Available in full text
October 1, 2018
Elsevier BV